Literature DB >> 8980365

Genital angiomyofibroblastoma. Comparison with aggressive angiomyxoma and other myxoid neoplasms of skin and soft tissue.

D M Ockner1, H Sayadi, P E Swanson, J H Ritter, M R Wick.   

Abstract

Angiomyofibroblastoma (AMFB) of the genital region is a relatively recently described tumor of the superficial soft tissues with a marked preference for female patients. Three cases of AMFB were reviewed, two of which involved adult men. To further elucidate the pathologic features of AMFB, these three cases were compared with 10 cases of aggressive angiomyxoma (AA), a salient diagnostic alternative, and 28 cases of other myxoid tumors that may show morphologic similarities to these neoplasms. Conventional histologic and immunohistochemical features of AMFBs were compared with those of AA, myxoid leiomyoma, myxoid leiomyosarcoma, myxoid liposarcoma, myxoid malignant fibrous histiocytoma, myxoid neurofibroma, and myxoid malignant peripheral nerve sheath tumor. The ultrastructure of two of the three AMFBs also was analyzed. Genital AMFBs were circumscribed, partially myxoid proliferations that demonstrated considerable variation in cellular density. Neoplastic elements were bland cytologically and showed both fusiform and epithelioid profiles, with a tendency to concentrate around intralesional blood vessels. Mitotic activity and necrosis were absent, and the vessels assumed an arborizing configuration and were venule or capillary sized. In contrast, all other tumor types evaluated were infiltrative, cytologically atypical, or both. All AMFBs showed immunoreactivity for vimentin, desmin, actin, and estrogen receptor protein. These results were shared by most examples of AA and smooth muscle tumors as well, but were not seen in any other neoplasms in this study. Electron microscopic findings in cases of AMFB supported the presence of myofibroblastic differentiation in the tumor cells. These results indicate that conventional morphologic analysis is paramount in the recognition of genital AMFB but that immunohistology may be helpful in a limited context in excluding other differential diagnoses. They also support the conclusion that AMFB, AA, and superficial smooth muscle tumors have similar morphotypes and immunohistologic attributes regardless of their origin in men or women.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8980365     DOI: 10.1093/ajcp/107.1.36

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  7 in total

1.  Angiomyofibroblastoma of the vulva.

Authors:  Jung-Won Seo; Kyoung-A Lee; Na-Ra Yoon; Jeong-Won Lee; Byoung-Gie Kim; Duk-Soo Bae
Journal:  Obstet Gynecol Sci       Date:  2013-09-14

2.  Angiomyofibroblastoma of the spermatic cord: a case report.

Authors:  Nikolaos E Tzanakis; George A Giannopoulos; Stamatis P Efstathiou; Georgios E Rallis; Nikolaos I Nikiteas
Journal:  J Med Case Rep       Date:  2010-03-04

3.  Angiomyofibroblastoma-like tumor of the scrotum.

Authors:  Seung Hyun Lee; Jung Wook Yang; Jung Mo Do; Deok Ha Seo; Jae Hun Jung; Ky Hyun Chung; Jong Sil Lee; Jae Seog Hyun
Journal:  Korean J Urol       Date:  2010-05-19

4.  Angiomyofibroblastoma arising from the posterior perivesical space: a case report with MR findings.

Authors:  Kyoung Ja Lim; Jeung Hee Moon; Dae Young Yoon; Ji Hyeon Cha; In Jae Lee; Seon Jeong Min
Journal:  Korean J Radiol       Date:  2008 Jul-Aug       Impact factor: 3.500

5.  Pedunculated angiomyofibroblastoma of the vulva: case report and review of the literature.

Authors:  Luca Giannella; Matteo Costantini; Kabala Mfuta; Alberto Cavazza; Lillo Bruno Cerami; Giorgio Gardini; Fausto Boselli
Journal:  Case Rep Med       Date:  2011-09-15

6.  Angiomyofibroblastoma-like tumor of the scrotum: A case report and literature review.

Authors:  Guoqing Ding; Yanlan Yu; Mei Jin; Jingyao Xu; Zhigen Zhang
Journal:  Oncol Lett       Date:  2013-12-06       Impact factor: 2.967

Review 7.  Practical Approach to the Diagnosis of the Vulvo-Vaginal Stromal Tumors: An Overview.

Authors:  Giuseppe Angelico; Stefano Marletta; Giuseppe Broggi; Paolo Vigneri; Giada Maria Vecchio; Lucia Salvatorelli; Gaetano Magro
Journal:  Diagnostics (Basel)       Date:  2022-01-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.